A detailed history of Procyon Advisors, LLC transactions in Haleon PLC stock. As of the latest transaction made, Procyon Advisors, LLC holds 162,911 shares of HLN stock, worth $1.59 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
162,911
Previous 160,156 1.72%
Holding current value
$1.59 Million
Previous $1.32 Million 30.33%
% of portfolio
0.12%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$8.32 - $10.7 $22,921 - $29,478
2,755 Added 1.72%
162,911 $1.72 Million
Q2 2024

Aug 02, 2024

BUY
$8.01 - $8.64 $228,212 - $246,162
28,491 Added 21.64%
160,156 $1.32 Million
Q1 2024

Apr 15, 2024

BUY
$8.02 - $8.67 $895,938 - $968,551
111,713 Added 559.91%
131,665 $1.12 Million
Q4 2023

Jan 18, 2024

BUY
$7.78 - $8.62 $31,936 - $35,385
4,105 Added 25.9%
19,952 $164,000
Q3 2023

Oct 10, 2023

BUY
$7.85 - $8.94 $124,398 - $141,672
15,847 New
15,847 $132,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $45B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Procyon Advisors, LLC Portfolio

Follow Procyon Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.